In 2014, a joint consensus document dealing with the management of antithrombotic therapy
in atrial fibrillation (AF) patients presenting with acute coronary syndrome (ACS) and/or …

Clinical practice in atrial fibrillation (AF) patient management is constantly evolving. In the
past 3 years, various new AF guidelines or focused updates have been published, given this …

The most recent atrial fibrillation (AF) guidelines delivered by European Society of
Cardiology (ESC) offer an updated approach to AF management, with the perspective of …

Background Preventing thrombosis is an important part of atrial fibrillation (AF) treatment.
However, it may increase the risk of bleeding, and bleeding risk assessment tools' predictive …

Background Assessing bleeding risk during the decision-making process of starting oral
anticoagulation (OAC) therapy in atrial fibrillation (AF) patients is essential. Several bleeding …

For Asian patients with nonvalvular atrial fibrillation (NVAF) using direct oral anticoagulants
(DOACs), performance of contemporary various bleeding risk scores in a real-world setting …

Purpose The aim of this clinical narrative review was to summarise the existing knowledge
on the use of anticoagulants and potential adverse events in older people at risk of falls with …

Aims Comparative data between the HAS‐BLED, GARFIELD‐AF and ORBIT score are
limited in anticoagulated Asian patients with atrial fibrillation (AF). We compared the …

Background: The HAS-BLED, HEMORR 2 HAGES, ATRIA, and ORBIT scores are used to
predict bleeding risk in anticoagulated patients with atrial fibrillation (AF). Recently, these …

Aims Bleeding risk assessment is recommended in guidelines for the management of atrial
fibrillation (AF). The HAS-BLED score was proposed prior to non-vitamin K antagonist oral …